Jane Street’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $374K | Sell |
115,578
-17,083
| -13% | -$49.9K | ﹤0.01% | 8682 |
|
|
2026
Q1 | $328K | Sell |
132,661
-1,043,919
| -89% | -$2.21M | ﹤0.01% | 9031 |
|
|
2025
Q4 | $2.41M | Buy |
1,176,580
+659,985
| +128% | +$1.91M | ﹤0.01% | 4445 |
|
|
2025
Q3 | $1.79M | Buy |
516,595
+255,127
| +98% | +$712K | ﹤0.01% | 5139 |
|
|
2025
Q2 | $575K | Sell |
261,468
-109,323
| -29% | -$179K | ﹤0.01% | 6658 |
|
|
2025
Q1 | $430K | Sell |
370,791
-702,617
| -65% | -$1.03M | ﹤0.01% | 7148 |
|
|
2024
Q4 | $1.36M | Buy |
1,073,408
+209,644
| +24% | +$534K | ﹤0.01% | 4825 |
|
|
2024
Q3 | $2.95M | Buy |
863,764
+573,628
| +198% | +$2.5M | ﹤0.01% | 3748 |
|
|
2024
Q2 | $1.35M | Buy |
290,136
+125,262
| +76% | +$707K | ﹤0.01% | 5184 |
|
|
2024
Q1 | $1.22M | Sell |
164,874
-1,363
| -0.8% | -$11.3K | ﹤0.01% | 5040 |
|
|
2023
Q4 | $1.68M | Buy |
166,237
+97,252
| +141% | +$854K | ﹤0.01% | 4630 |
|
|
2023
Q3 | $538K | Sell |
68,985
-200,155
| -74% | -$1.72M | ﹤0.01% | 6188 |
|
|
2023
Q2 | $2.22M | Buy |
269,140
+154,871
| +136% | +$1.35M | ﹤0.01% | 4017 |
|
|
2023
Q1 | $828K | Buy |
114,269
+7,063
| +7% | +$62.8K | ﹤0.01% | 5370 |
|
|
2022
Q4 | $951K | Sell |
107,206
-15,244
| -12% | -$167K | ﹤0.01% | 5057 |
|
|
2022
Q3 | $1.5M | Sell |
122,450
-6,505
| -5% | -$101K | ﹤0.01% | 4684 |
|
|
2022
Q2 | $1.53M | Buy |
128,955
+68,879
| +115% | +$923K | ﹤0.01% | 4673 |
|
|
2022
Q1 | $1.14M | Sell |
60,076
-175,382
| -74% | -$3.26M | ﹤0.01% | 5856 |
|
|
2021
Q4 | $6.25M | Buy |
235,458
+165,759
| +238% | +$5.71M | ﹤0.01% | 2505 |
|
|
2021
Q3 | $2.86M | Sell |
69,699
-15,664
| -18% | -$858K | ﹤0.01% | 3746 |
|
|
2021
Q2 | $4.83M | Sell |
85,363
-163,563
| -66% | -$6.04M | ﹤0.01% | 2698 |
|
|
2021
Q1 | $10.5M | Buy |
248,926
+113,804
| +84% | +$6.48M | 0.01% | 1507 |
|
|
2020
Q4 | $9.47M | Buy |
135,122
+95,322
| +240% | +$3.92M | ﹤0.01% | 1460 |
|
|
2020
Q3 | $1.12M | Sell |
39,800
-49,307
| -55% | -$1.61M | ﹤0.01% | 3917 |
|
|
2020
Q2 | $2.63M | Buy |
+89,107
| New | +$2.33M | ﹤0.01% | 2679 |
|
|
2020
Q1 | – | Sell |
-20,644
| Closed | -$521K | – | 5426 |
|
|
2019
Q4 | $611K | Buy |
+20,644
| New | +$516K | ﹤0.01% | 3437 |
|
|
2019
Q2 | – | Sell |
-54,990
| Closed | -$1.34M | – | 5242 |
|
|
2019
Q1 | $1.34M | Buy |
54,990
+14,440
| +36% | +$327K | ﹤0.01% | 2465 |
|
|
2018
Q4 | $923K | Buy |
+40,550
| New | +$1.1M | ﹤0.01% | 2682 |
|
|
2018
Q2 | – | Sell |
-21,717
| Closed | -$769K | – | 5079 |
|
|
2018
Q1 | $720K | Buy |
+21,717
| New | +$774K | ﹤0.01% | 3047 |
|
|
2017
Q4 | – | Sell |
-18,871
| Closed | -$453K | – | 4680 |
|
|
2017
Q3 | $453K | Buy |
+18,871
| New | +$359K | ﹤0.01% | 3223 |
|
Other funds holding EDIT
TCM
ACM
CC
RCM
PBA
OM
WP
Jane Street's EDIT Position: Q2 2026 in Review
Jane Street reduced its Editas Medicine (EDIT) stake by 13% in Q2 2026, selling an estimated $49.9K and leaving 115,578 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #8682.
Jane Street first reported a position in EDIT in Q3 2017 and has held it in 30 quarters since. The position peaked at $10.5M in Q1 2021. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.
- Jane Street held 115,578 shares of Editas Medicine worth $374K as of Q2 2026.
- Jane Street sold 17,083 Editas Medicine shares in Q2 2026, an estimated $49.9K.
- Editas Medicine made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8682 holding.
- Jane Street first reported a position in Editas Medicine in Q3 2017 and has held it in 30 quarters since.
- Jane Street's Editas Medicine position peaked at $10.5M in Q1 2021.
- 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.